Search All News
After being diagnosed in 2001 with chronic lymphocytic leukemia and again in 2018 with lung cancer, Mary Ann is now successfully managing her disease and returning to her calling as an actress.
A new study reveals that Black and Hispanic cancer patients, following a COVID-19 diagnosis, are suffering from greater treatment delays or discontinuations altogether.
A study, led by Benjamin Izar, MD, is drawing the most detailed picture yet of SARS-CoV-2 infection in the lung, and provides leads to why severe cases of COVID-19 experience long-term complications.
Kenneth Olive shares what it was like and lessons learned from jumping into relief efforts during the start of the COVID-19 pandemic.
- May 27, 2020
The HICCC has awarded three new pilot grants to Columbia University faculty members whose research ideas are targeting accelerated solutions to combat COVID-19.
- May 19, 2020
On Monday, March 2nd, the first confirmed COVID-19 patient in New York arrived at NewYork-Presbyterian Hospital/CUIMC. That afternoon, a team of oncology nurses and staff sprung to action.
- May 18, 2020
Alison Schroeter is a clinical trials oncology nurse at the Herbert Irving Comprehensive Cancer Center (HICCC) and was redeployed to assist COVID-19 clinical trials at NewYork-Presbyterian Hospital.
- May 8, 2020
Aaron Garcia, a graduate student at Columbia University’s School of Nursing, is currently working as a nurse technician at NewYork-Presbyterian Hospital on the COVID-19 front lines.
- May 4, 2020
Dr. Matthew Dallos and colleagues have opened the first clinical trial testing an anti-IL-8 compound as a potential therapy against COVID-19.
- April 28, 2020
The Columbia COVID-19 Biobank has been up and running for just three weeks. The idea is to lend immediate support and invaluable resources to investigators working toward a cure for COVID-19.
- April 2, 2020
Researchers from the Herbert Irving Comprehensive Cancer Center (HICCC) at NewYork-Presbyterian/Columbia are swiftly transforming their discoveries and innovation in cancer to address COVID-19.